Unraveling Coronavirus Structure for Effective Vaccine and MedicationFebruary 3, 2021
While vaccinations against SARS-CoV-2 have already begun in many countries, effective medication for COVID-19 treatment has not yet been identified. Scientists at Max Planck Institutes (MPI) are now closely investigating the surface structures of SARS-CoV-2 and the processes by which the virus replicates in infected cells to find new targets for possible therapies.
Martin Beck and Gerhard Hummer and their working groups at the Max Planck Institute of Biophysics in Frankfurt, Germany have been studying the structure of the spike protein in detail. Beck deciphered the protein structure at near-atomic resolution. From this data, Hummer was able to analyze the properties of the spike protein in its natural environment in computer simulations. The researchers then came to some surprising conclusions.
The stalk with which the protein is anchored on the surface of the virus proved to be unexpectedly flexible. Hummer explained that the protein needs this mobility to optimally bind to the receptor on the target cell. The analyses also showed that antibodies can bind well to the upper part of the spike protein, while other parts of the protein are coated with sugar chains to protect them from being recognized by the immune system. "With this knowledge, we can now identify areas that may be targets for vaccines or therapeutic antibodies", explains Hummer.
For more details, read the article in the MPI Newsroom.
You might also like:
- Rush Scientists Develop Potential COVID-19 Drug
- UChicago Creates First Computational Model of Entire COVID-19 Virus
- Pocket K No. 58: COVID-19 Treatment Efforts Using Plant Technologies
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- Unraveling Coronavirus Structure for Effective Vaccine and Medication
News from Around the World
- ISAAA Report on Global Adoption of GM Crops in 2019 Now Available
- GM Mosquitoes Key to Stopping Zika Virus Spread
- Scientists Discover A New Tool to Immediately Detect Bitterness in Almonds
- Researchers Work on Making Wheat and Peanuts Less Allergenic
- Golden Rice Could Supply Up to 50% of the Average Daily Requirement of Vitamin A
- Punjab Seed Council Approved Two New Bt Cotton Varieties
- Team Effort Produces High-Quality Reference Genome Sequence of Switchgrass
Plant Breeding Innovations
- UCalgary Produces High-Yielding Gene Edited Canola
- Scientists Successful in Obtaining Heritable Gene Targeted Events In Tobacco
- TALEN Beats CRISPR-Cas9 in Editing Tightly-packed DNA
- Gene-edited Canola Shows Resistance to White Mold
Read the latest:
- Crop Biotech Update (January 25, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
Subscribe to CBU: